Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, UT

Clinical Trial Details

Overview

Research Study Summary

Alzheimer's Research Study

Purpose

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study to Assess Safety, Tolerability, Immunogenicity, Pharmacodynamic Response, and Pharmacokinetics of Intravenous Infusions of BAN2401 in Subjects with Mild to Moderate Alzheimer's Disease

Patient Inclusion Criteria:

  • Diagnosis or symptoms of probable mild to moderate AD
  • Age 50+
  • Weight 110-220 lbs
  • If Power of Attorney has been transferred, the Legal Authorized Representative must attend the screening visit

Patient Exclusion Criteria:

  • History of heart or lung disease, stroke, mini-stroke or seizures in the past year
  • Untreated psychiatric conditions

To Learn more
Phase

1

Gender

Both Male and Female

Age

50 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Cher Struck, Director, Marketing and Recruiting
Lifetree Clinical Research
3838 South 700 East Suite 202
Salt Lake City, UT 84106
Phone: 801-269-8200

View Map

Research Center Information: Lifetree Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 168951

Date Last Changed: July 23, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.